Arqt stock forecast.

Compare it to the S&P 500, one of the broad stock market’s most popular indices. Between March 1, 2018, and March 1, 2023, Apple’s closing stock price increased from $43.75 to $145.31–a 232% ...

Arqt stock forecast. Things To Know About Arqt stock forecast.

ARQT Stock 12 Months Forecast. $25.29. (936.48% Upside) Based on 7 Wall Street analysts offering 12 month price targets for Arcutis Biotherapeutics in the last 3 months. The average price target is $25.29 with a high forecast of $50.00 and a low forecast of $4.00. The average price target represents a 936.48% change from the last price of $2.44. The shares of common stock are being sold at a public offering price of $2.50 per share and the pre-funded warrants are being sold at a public offering price of $2.4999 per pre-funded warrant ...All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange ...37.23M. MSFT. 378.61. +0.31%. 20.54M. View today's Arcutis Biotherapeutics Inc stock price and latest ARQT news and analysis. Create real-time notifications to follow any changes in the live stock ...

Shares of Arcutis Biotherapeutics ( ARQT -2.71%) were down 15.7% for the week as of 2:45 p.m. on Thursday, according to data provided by S&P Global Market Intelligence. The healthcare company's ...

Arcutis Biotherapeutics Stock Chart and Share Price Forecast, Short-Term "ARQT" Stock Prediction for Next Days and Weeks Walletinvestor.com Arcutis Biotherapeutics Inc (ARQT) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024

Arcutis Biotherapeutics (NASDAQ:ARQT) has observed the following analyst ratings within the last quarter: These 6 analysts have an average price target of $34.83 versus the current price of ...The 12-month stock price forecast is $3.15, which is an increase of 1,189.93% from the latest price. Price Target. $3.15 (1,189.93% upside) Analyst ... Better Therapeutics (NASDAQ:BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT) The most oversold stocks in the health care sector presents an opportunity to buy into …According to . 1 Wall Street analyst that have issued a 1 year THRD price target, the average THRD price target is $7.00, with the highest THRD stock price forecast at $7.00 and the lowest THRD stock price forecast at $7.00.Arcutis Biotherapeutics Stock Price, News & Analysis (NASDAQ:ARQT) $1.99 +0.15 (+8.15%) (As of 12/1/2023 ET) Compare Today's Range $1.76 $2.00 50-Day Range $1.84 $5.83 52-Week Range $1.76 $18.04 Volume 2.93 million shs Average Volume 2.67 million shs Market Capitalization $187.82 million P/E Ratio N/A Dividend Yield

Arcutis Biotherapeutics Inc (ARQT) stock is down -19.17% while the S&P 500 has gained 0.24% as of 11:18 AM on Wednesday, May 10. ARQT has fallen -$2.84 from the previous closing price of $14.82 on volume of 1,864,299 shares. Over the past year the S&P 500 has gained 3.46% while ARQT has fallen -36.41%.

Analyst projections state that ARQT is forecast to be at a low of $4.00 and a high of $44.00. In order for the stock price to hit the forecast high, the stock would need to plunge -2122.22% from its current level, while the stock would need to crash -102.02% from its current level to reach the projected low.

Currently, the Dow is -8 points, the S&P 500 is -7, the Nasdaq -39 points and the small-cap Russell 2000 -2. Only the Nasdaq is down over the past week of trading, with the blue-chip Dow leading ...The consensus price target of analysts on Wall Street is $36.63, which implies an increase of 91.73% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $6.00 and $57.00 respectively. As a result, ARQT is trading at a discount of -1781.19% off the target high and -98.02% off the low.Find the latest Savara Inc. (SVRA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid Term ...Nov 9, 2023 · The consensus price target of analysts on Wall Street is $24.50, which implies an increase of 91.02% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $4.00 and $50.00 respectively. As a result, ARQT is trading at a discount of -2172.73% off the target high and -81.82% off the low. Arcutis Biotherapeutics Inc (ARQT) stock is down -19.17% while the S&P 500 has gained 0.24% as of 11:18 AM on Wednesday, May 10. ARQT has fallen -$2.84 from the previous closing price of $14.82 on volume of 1,864,299 shares. Over the past year the S&P 500 has gained 3.46% while ARQT has fallen -36.41%.UiPath’s stock soars after profit, revenue and ARR rise above forecasts Nov. 30, 2023 at 4:46 p.m. ET by Tomi Kilgore UiPath Shares Jump 13% on Surging 3Q RevenueStock analysis for Arcutis Biotherapeutics Inc (ARQT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Read about Arcutis Biotherapeutics Inc Ordinary Shares (ARQT:XNAS) stock and today's latest news and financial updates.According to the issued ratings of 9 analysts in the last year, the consensus rating for Arcutis Biotherapeutics stock is Moderate Buy based on the current 3 hold ratings and 6 buy ratings for ARQT. The average twelve-month price prediction for Arcutis Biotherapeutics is $29.67 with a high price target of $57.00 and a low price target of $6.00 ...The S&P 500 is headed for a new all-time high in 2024 as the Fed pivots and stocks enter a Goldilocks no-recession scenario, JPMorgan wealth strategist says. The S&P 500 hitting a new record high ...According to . 1 Wall Street analyst that have issued a 1 year THRD price target, the average THRD price target is $7.00, with the highest THRD stock price forecast at $7.00 and the lowest THRD stock price forecast at $7.00.Compare it to the S&P 500, one of the broad stock market’s most popular indices. Between March 1, 2018, and March 1, 2023, Apple’s closing stock price increased from $43.75 to $145.31–a 232% ...The shares of common stock are being sold at a public offering price of $2.50 per share and the pre-funded warrants are being sold at a public offering price of $2.4999 per pre-funded warrant ...Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Arcutis Biotherapeutics Inc have a median target of 10.00, with a high estimate of 44.00 and a low estimate of 4.00. The ...

1.78%. $11.97B. Eisai Co. Ltd. 0.50%. ¥2.18T. ARQT | Complete Arcutis Biotherapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

ARQT has an Altman Z-Score of -5.32 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for Arcutis Biotherapeutics, Inc. (ARQT) stock, including valuation metrics, financial numbers, share information and more.Analyst Forecast. According to 9 analysts, the average rating for ARQT stock is "Buy." The 12-month stock price forecast is $27.25, which is an increase of 1,349.47% from the latest price.Arcutis Biotherapeutics. Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its piepline consists of topical treatments for plaque psoriasis, atopic dermatitis, eczema, vitiligo, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and ...Current. -$1.05. 1 Month Ago. -$1.17. 3 Months Ago. -$1.15. Arcutis Biotherapeutics Inc. analyst estimates, including ARQT earnings per share estimates and analyst recommendations.66.61%. Get the latest Arcutis Biotherapeutics Inc (ARQT) real-time quote, historical performance, charts, and other financial information to help you make more informed …People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.Find the latest Gamida Cell Ltd. (GMDA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...ARQT Stock 12 Months Forecast. $25.29. (936.48% Upside) Based on 7 Wall Street analysts offering 12 month price targets for Arcutis Biotherapeutics in the last 3 months. The average price target is $25.29 with a high forecast of $50.00 and a low forecast of $4.00. The average price target represents a 936.48% change from the last price of $2.44.The Arcutis Biotherapeutics Inc stock price fell by -0.529% on the last day (Wednesday, 22nd Nov 2023) from $1.89 to $1.88. During the last trading day the stock fluctuated 17.51% from a day low at $1.77 to a day high of $2.08. The price has fallen in 6 of the last 10 days and is down by -14.55% for this period.Shares of Arcutis Biotherapeutics ( ARQT -2.71%) were down 15.7% for the week as of 2:45 p.m. on Thursday, according to data provided by S&P Global Market Intelligence. The healthcare company's ...

On Monday, Arcutis Biotherapeutics Inc [NASDAQ:ARQT] saw its stock fall -3.45% to $1.96. On the same session, the stock had its day’s lowest price of $1.88, but rose to a high of $2.11. Over the last five days, the stock has lost -3.92%. Arcutis Biotherapeutics Inc shares have fallen nearly -86.76% since the year began.

Their ORCL share price targets range from $93.00 to $150.00. On average, they anticipate the company's share price to reach $124.23 in the next year. This suggests a possible upside of 6.9% from the stock's current price. View analysts price targets for ORCL or view top-rated stocks among Wall Street analysts.

Nov 6, 2023 · ARQT stock had an impressive performance on November 6, 2023, based on the information provided by CNN Money. The 12-month price forecasts from 8 analysts for Arcutis Biotherapeutics Inc had a median target of $21.00, with a high estimate of $50.00 and a low estimate of $4.00. The next CPI report will come out on Dec. 12. The Fed has raised interest rates to 5.25% to 5.5% in an effort to tame prices as they surged in summer 2022, when prices were on average 9% higher ...Arcutis Biotherapeutics ARQT is set to give its latest quarterly earnings report on Tuesday, 2023-02-28. Here's what investors need to know before the announcement. Analysts estimate that Arcutis ...GuruFocus • 17 days ago. Related Stocks: ARQT, AAPL, AMZN, META ... Arcutis Biotherapeutics price target lowered to $8 from $22 at NeedhamThe Fly • 25 days ago.Oct 24, 2023 · Celebrations may be in order for Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) shareholders, with the analysts delivering a significant upgrade to their statutory estimates for the company.The ... 13 нояб. 2023 г. ... On November 13, 2023, ARQT stock showed mixed performance, with a slight decrease in the opening price compared to the previous close. The stock ...The average one-year price target for ARQT / Arcutis Biotherapeutics Inc is $11.39. The forecasts range from a low of $4.04 to a high of $21. A stock’s price target is the price at …UiPath’s stock soars after profit, revenue and ARR rise above forecasts Nov. 30, 2023 at 4:46 p.m. ET by Tomi Kilgore UiPath Shares Jump 13% on Surging 3Q Revenue

Find the latest Arcutis Biotherapeutics, Inc. (ARQT) stock quote, history, news and other vital information to help you with your stock trading and investing.18.04 -87.30% Year-to-Date Quote Profile News Charts Forecasts Financials Shareholders Competitors vs. Health Technology News Chart Latest ARQT News | Press Releases After Plunging -35.64% in 4...The goal of this article is to provide a practical introductory guide to neural networks for forecasting financial time series data using Azure Deep Learning Virtual Machine. A multiple step ...Find real-time HAL - Halliburton Co stock quotes, company profile, news and forecasts from CNN Business.Instagram:https://instagram. paypal dollar5foreign exchange trading demo accountbroadcom stock predictionpolished.com Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.The next CPI report will come out on Dec. 12. The Fed has raised interest rates to 5.25% to 5.5% in an effort to tame prices as they surged in summer 2022, when prices were on average 9% higher ... eqqqtoptier trading Mumbai Stock Forecast . Bombay Stock Exchange Stock Forecast BSE Share Price Predictions with Smart Prognosis Chart - 2023-2024 You can find here the Best Indian Stocks to buy! Showing 1-100 of 3,290 items. Forecast Range Filter. From % To % Filter Reset / Default. Rating Name Price (INR) ...After registering a 0.44% upside in the last session, Arcutis Biotherapeutics Inc (ARQT) has traded red over the past five days. The stock hit a weekly high of 2.46 this Wednesday, 11/01/23, jumping 0.44% in its intraday price action. The 5-day price performance for the stock is -5.04%, and -50.55% over 30 days. how to paper trade on webull Find real-time ARCT - Arcturus Therapeutics Holdings Inc stock quotes, company profile, news and forecasts from CNN Business.500. Check out the ideas and forecasts on stocks from top authors of our community. They share predictions and technical outlook of the market to find trending stocks of different countries: India, USA, UK, Japan, etc. Join our financial community to start learning more about the markets. — India.